According to research published in The Lancet Medical Journal, mixing two different vaccines resulted in more short-lived side effects of fatigue and headaches in patients. The study didn’t point to any safety issues and stated that the stronger side effects vanished after a few days. Researchers and public health officials from many low and middle-income nations are examining vaccine shot blending strategies to cope with vaccine scarcity. The mixed regimen is known as a heterologous boost.
A recent correspondence published in The Lancet Journal reported the results of a heterologous prime-boost COVID-19 vaccination in a multi-centre trial conducted in UK. The study compared four prime-boost permutations of the ChAdOx1 (AstraZeneca) and BNT162b2 (Pfizer-BioNTech) vaccines at 28-day and 84-day intervals in a total of 830 participants. The following results were noted: Higher systemic…
